{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:24:18Z","timestamp":1790321058520,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81200295"],"award-info":[{"award-number":["81200295"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12944-015-0139-6","type":"journal-article","created":{"date-parts":[[2015,10,24]],"date-time":"2015-10-24T10:09:15Z","timestamp":1445681355000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Resveratrol ameliorates hepatic steatosis and inflammation in methionine\/choline-deficient diet-induced steatohepatitis through regulating autophagy"],"prefix":"10.1186","volume":"14","author":[{"given":"Guiyuan","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoqin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,24]]},"reference":[{"issue":"2","key":"139_CR1","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/hep.21248","volume":"44","author":"JD Browning","year":"2006","unstructured":"Browning JD. Statins and hepatic steatosis: perspectives from the Dallas Heart Study. Hepatology. 2006;44(2):466\u201371.","journal-title":"Hepatology"},{"key":"139_CR2","doi-asserted-by":"crossref","unstructured":"Mavrogiannaki AN, Migdalis IN. Nonalcoholic Fatty Liver Disease, Diabetes Mellitus and Cardiovascular Disease: Newer Data. Int J Endocrinol. 2013; doi: 10.1155\/2013\/450639 .","DOI":"10.1155\/2013\/450639"},{"issue":"1","key":"139_CR3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2005.05.041","volume":"129","author":"CP Day","year":"2005","unstructured":"Day CP. Natural history of NAFLD: remarkably benign in the absence of cirrhosis. Gastroenterology. 2005;129(1):375\u20138.","journal-title":"Gastroenterology"},{"issue":"38","key":"139_CR4","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3748\/wjg.v16.i38.4773","volume":"16","author":"G Tarantino","year":"2010","unstructured":"Tarantino G, Savastano S, Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone\/growth factor\/adipokine imbalance. World J Gastroenterol. 2010;16(38):4773\u201383.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"139_CR5","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1530\/JOE-13-0201","volume":"218","author":"M Asrih","year":"2013","unstructured":"Asrih M, Jornayvaz FR. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance. J Endocrinol. 2013;218(3):R25\u201336.","journal-title":"J Endocrinol"},{"issue":"4","key":"139_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jnutbio.2010.12.013","volume":"23","author":"H Guo","year":"2012","unstructured":"Guo H, Xia M, Zou T, Ling W, Zhong R, Zhang W. Cyanidin 3-glucoside attenuates obesity-associated insulin resistance and hepatic steatosis in high-fat diet-fed and db\/db mice via the transcription factor FoxO1. J Nutr Biochem. 2012;23(4):349\u201360.","journal-title":"J Nutr Biochem"},{"issue":"1","key":"139_CR7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12263-013-0373-3","volume":"9","author":"CW Xiao","year":"2014","unstructured":"Xiao CW, Wood CM, Weber D, Aziz SA, Mehta R, Griffin P, et al. Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats. Genes Nutr. 2014;9(1):373.","journal-title":"Genes Nutr"},{"issue":"1","key":"139_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1743-7075-9-27","volume":"9","author":"HH Jang","year":"2012","unstructured":"Jang HH, Park MY, Kim HW, Lee YM, Hwang KA, Park JH, et al. Black rice (Oryza sativa L.) extract attenuates hepatic steatosis in C57BL\/6\u00a0J mice fed a high-fat diet via fatty acid oxidation. Nutr Metab (Lond). 2012;9(1):27.","journal-title":"Nutr Metab (Lond)"},{"issue":"6","key":"139_CR9","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"JA Baur","year":"2006","unstructured":"Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov. 2006;5(6):493\u2013506.","journal-title":"Nat Rev Drug Discov"},{"key":"139_CR10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-511X-11-76","volume":"11","author":"AA Qureshi","year":"2012","unstructured":"Qureshi AA, Guan XQ, Reis JC, Papasian CJ, Jabre S, Morrison DC, et al. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis. 2012;11:76.","journal-title":"Lipids Health Dis."},{"key":"139_CR11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-511X-11-56","volume":"11","author":"Q Chen","year":"2012","unstructured":"Chen Q, Wang E, Ma L, Zhai P. Dietary resveratrol increases the expression of hepatic 7alpha-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL\/6\u00a0J mice. Lipids Health Dis. 2012;11:56.","journal-title":"Lipids Health Dis."},{"issue":"8","key":"139_CR12","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jnutbio.2005.01.017","volume":"16","author":"P Signorelli","year":"2005","unstructured":"Signorelli P, Ghidoni R. Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem. 2005;16(8):449\u201366.","journal-title":"J Nutr Biochem"},{"issue":"5","key":"139_CR13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jhep.2012.12.012","volume":"58","author":"M Pascoli Di","year":"2013","unstructured":"Di Pascoli M, Divi M, Rodriguez-Vilarrupla A, Rosado E, Gracia-Sancho J, Vilaseca M, et al. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats. J Hepatol. 2013;58(5):904\u201310.","journal-title":"J Hepatol"},{"key":"139_CR14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1479-5876-9-59","volume":"9","author":"C Salado","year":"2011","unstructured":"Salado C, Olaso E, Gallot N, Valcarcel M, Egilegor E, Mendoza L, et al. Resveratrol prevents inflammation-dependent hepatic melanoma metastasis by inhibiting the secretion and effects of interleukin-18. J Transl Med. 2011;9:59.","journal-title":"J Transl Med."},{"issue":"8","key":"139_CR15","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1002\/mnfr.201500016","volume":"59","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Chen ML, Zhou Y, Yi L, Gao YX, Ran L, et al. Resveratrol improves hepatic steatosis by inducing autophagy through the cAMP signaling pathway. Mol Nutr Food Res. 2015;59(8):1443\u201357.","journal-title":"Mol Nutr Food Res"},{"key":"139_CR16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-11-35","volume":"11","author":"W Zhu","year":"2014","unstructured":"Zhu W, Chen S, Li Z, Zhao X, Li W, Sun Y, et al. Effects and mechanisms of resveratrol on the amelioration of oxidative stress and hepatic steatosis in KKAy mice. Nutr Metab (Lond). 2014;11:35.","journal-title":"Nutr Metab (Lond)."},{"issue":"7\u20138","key":"139_CR17","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.nut.2013.11.016","volume":"30","author":"JM Andrade","year":"2014","unstructured":"Andrade JM, Paraiso AF, de Oliveira MV, Martins AM, Neto JF, et al. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation. Nutrition. 2014;30(7\u20138):915\u20139.","journal-title":"Nutrition"},{"key":"139_CR18","doi-asserted-by":"crossref","unstructured":"Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O\u2019Moore-Sullivan TM, Lee P, et al. Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2014;12(12):2092\u20132103 e2091-2096.","DOI":"10.1016\/j.cgh.2014.02.024"},{"issue":"2","key":"139_CR19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.22039","volume":"47","author":"B Shen","year":"2008","unstructured":"Shen B, Yu J, Wang S, Chu ES, Wong VW, Zhou X, et al. Phyllanthus urinaria ameliorates the severity of nutritional steatohepatitis both in vitro and in vivo. Hepatology. 2008;47(2):473\u201383.","journal-title":"Hepatology"},{"issue":"9","key":"139_CR20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.nutres.2012.08.004","volume":"32","author":"MM Poulsen","year":"2012","unstructured":"Poulsen MM, Larsen JO, Hamilton-Dutoit S, Clasen BF, Jessen N, Paulsen SK, et al. Resveratrol up-regulates hepatic uncoupling protein 2 and prevents development of nonalcoholic fatty liver disease in rats fed a high-fat diet. Nutr Res. 2012;32(9):701\u20138.","journal-title":"Nutr Res"},{"issue":"6","key":"139_CR21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2337\/db11-1498","volume":"61","author":"BT Jeon","year":"2012","unstructured":"Jeon BT, Jeong EA, Shin HJ, Lee Y, Lee DH, Kim HJ, et al. Resveratrol attenuates obesity-associated peripheral and central inflammation and improves memory deficit in mice fed a high-fat diet. Diabetes. 2012;61(6):1444\u201354.","journal-title":"Diabetes"},{"key":"139_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","volume":"52","author":"P Xin","year":"2013","unstructured":"Xin P, Han H, Gao D, Cui W, Yang X, Ying C, et al. Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. Food Chem Toxicol. 2013;52:12\u20138.","journal-title":"Food Chem Toxicol."},{"key":"139_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jff.2013.12.006","volume":"6","author":"P Scicchitano","year":"2014","unstructured":"Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, et al. Nutraceuticals and dyslipidaemia: Beyond the common therapeutics. Journal of Functional Foods. 2014;6:11\u201332.","journal-title":"Journal of Functional Foods."},{"issue":"10","key":"139_CR24","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.nutres.2014.09.005","volume":"34","author":"F Faghihzadeh","year":"2014","unstructured":"Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease. Nutr Res. 2014;34(10):837\u201343.","journal-title":"Nutr Res"},{"issue":"7","key":"139_CR25","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.nutres.2015.05.006","volume":"35","author":"QR Pan","year":"2015","unstructured":"Pan QR, Ren YL, Liu WX, Hu YJ, Zheng JS, Xu Y, et al. Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats. Nutr Res. 2015;35(7):576\u201384.","journal-title":"Nutr Res"},{"key":"139_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.phrs.2015.03.005","volume":"95\u201396","author":"S Heeboll","year":"2015","unstructured":"Heeboll S, Thomsen KL, Clouston A, Sundelin EI, Radko Y, Christensen LP, et al. Effect of resveratrol on experimental non-alcoholic steatohepatitis. Pharmacol Res. 2015;95\u201396:34\u201341.","journal-title":"Pharmacol Res."},{"key":"139_CR27","doi-asserted-by":"crossref","unstructured":"Heeboll S, El-Houri RB, Hellberg YE, Haldrup D, Pedersen SB, Jessen N, et al. The effect of resveratrol on experimental non-alcoholic fatty liver disease depends on severity of pathology and timing of treatment. J Gastroenterol Hepatol. 2015; doi: 10.1111\/jgh.13151","DOI":"10.1111\/jgh.13151"},{"issue":"7242","key":"139_CR28","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nature07976","volume":"458","author":"R Singh","year":"2009","unstructured":"Singh R, Kaushik S, Wang Y, Xiang Y, Novak I, Komatsu M, et al. Autophagy regulates lipid metabolism. Nature. 2009;458(7242):1131\u20135.","journal-title":"Nature"},{"issue":"4","key":"139_CR29","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","volume":"142","author":"V Hernandez-Gea","year":"2012","unstructured":"Hernandez-Gea V, Ghiassi-Nejad Z, Rozenfeld R, Gordon R, Fiel MI, Yue Z, et al. Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues. Gastroenterology. 2012;142(4):938\u201346.","journal-title":"Gastroenterology"},{"issue":"3","key":"139_CR30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/exd.12337","volume":"23","author":"ES Kim","year":"2014","unstructured":"Kim ES, Chang H, Choi H, Shin JH, Park SJ, Jo YK, et al. Autophagy induced by resveratrol suppresses alpha-MSH-induced melanogenesis. Exp Dermatol. 2014;23(3):204\u20136.","journal-title":"Exp Dermatol"},{"issue":"7","key":"139_CR31","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcp.24903","volume":"230","author":"YP Chang","year":"2015","unstructured":"Chang YP, Ka SM, Hsu WH, Chen A, Chao LK, Lin CC, et al. Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy. J Cell Physiol. 2015;230(7):1567\u201379.","journal-title":"J Cell Physiol"},{"key":"139_CR32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","volume":"445","author":"I Tanida","year":"2008","unstructured":"Tanida I, Ueno T, Kominami E. LC3 and Autophagy. Methods Mol Biol. 2008;445:77\u201388.","journal-title":"Methods Mol Biol."},{"issue":"4","key":"139_CR33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00281-010-0220-1","volume":"32","author":"Y Ichimura","year":"2010","unstructured":"Ichimura Y, Komatsu M. Selective degradation of p62 by autophagy. Semin Immunopathol. 2010;32(4):431\u20136.","journal-title":"Semin Immunopathol"},{"issue":"6","key":"139_CR34","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/hep.26461","volume":"58","author":"B Staels","year":"2013","unstructured":"Staels B, Rubenstrunk A, Noel B, Rigou G, Delataille P, Millatt LJ, et al. Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha\/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Hepatology. 2013;58(6):1941\u201352.","journal-title":"Hepatology"},{"issue":"7384","key":"139_CR35","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature10809","volume":"482","author":"J Henao-Mejia","year":"2012","unstructured":"Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179\u201385.","journal-title":"Nature"},{"key":"139_CR36","doi-asserted-by":"crossref","unstructured":"Hassoun E, Mettling C. Dichloroacetate and Trichloroacetate Toxicity in AML12 Cells: Role of Oxidative Stress. J Biochem Mol Toxicol. 2015; doi: 10.1002\/jbt.21720","DOI":"10.1002\/jbt.21720"},{"issue":"6","key":"139_CR37","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313\u201321.","journal-title":"Hepatology"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-015-0139-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T18:07:40Z","timestamp":1567274860000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.lipidworld.com\/content\/14\/1\/134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,24]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1186\/s12944-015-0139-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,24]]},"article-number":"134"}}